83 related articles for article (PubMed ID: 9589346)
1. Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents.
Boone CW; Bacus JW; Bacus JV; Steele VE; Kelloff GJ
J Cell Biochem Suppl; 1997; 28-29():1-20. PubMed ID: 9589346
[TBL] [Abstract][Full Text] [Related]
2. Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trials.
Boone CW; Bacus JW; Bacus JV; Steele VE; Kelloff GJ
Proc Soc Exp Biol Med; 1997 Nov; 216(2):151-65. PubMed ID: 9349684
[TBL] [Abstract][Full Text] [Related]
3. Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia.
Boone CW; Kelloff GJ
J Cell Biochem Suppl; 1994; 19():10-22. PubMed ID: 7823580
[TBL] [Abstract][Full Text] [Related]
4. Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy.
Boone CW; Kelloff GJ; Steele VE
Cancer Res; 1992 Apr; 52(7):1651-9. PubMed ID: 1551096
[TBL] [Abstract][Full Text] [Related]
5. Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.
Boone CW; Kelloff GJ
Cancer Surv; 1998; 32():133-47. PubMed ID: 10489626
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.
Kelloff GJ; Sigman CC; Johnson KM; Boone CW; Greenwald P; Crowell JA; Hawk ET; Doody LA
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):127-37. PubMed ID: 10698472
[TBL] [Abstract][Full Text] [Related]
7. Biomarker end-points in cancer chemoprevention trials.
Boone CW; Kelloff GJ
IARC Sci Publ; 1997; (142):273-80. PubMed ID: 9354926
[TBL] [Abstract][Full Text] [Related]
8. Surrogate end-point biomarkers in chemopreventive drug development.
Kelloff GJ; Sigman CC; Hawk ET; Johnson KM; Crowell JA; Guyton KZ
IARC Sci Publ; 2001; 154():13-26. PubMed ID: 11220652
[TBL] [Abstract][Full Text] [Related]
9. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
Kelloff GJ; Lippman SM; Dannenberg AJ; Sigman CC; Pearce HL; Reid BJ; Szabo E; Jordan VC; Spitz MR; Mills GB; Papadimitrakopoulou VA; Lotan R; Aggarwal BB; Bresalier RS; Kim J; Arun B; Lu KH; Thomas ME; Rhodes HE; Brewer MA; Follen M; Shin DM; Parnes HL; Siegfried JM; Evans AA; Blot WJ; Chow WH; Blount PL; Maley CC; Wang KK; Lam S; Lee JJ; Dubinett SM; Engstrom PF; Meyskens FL; O'Shaughnessy J; Hawk ET; Levin B; Nelson WG; Hong WK;
Clin Cancer Res; 2006 Jun; 12(12):3661-97. PubMed ID: 16778094
[TBL] [Abstract][Full Text] [Related]
10. Intraepithelial and postinvasive neoplasia as a stochastic continuum of clonal evolution, and its relationship to mechanisms of chemopreventive drug action.
Boone CW; Kelloff GJ; Freedman LS
J Cell Biochem Suppl; 1993; 17G():14-25. PubMed ID: 8007692
[TBL] [Abstract][Full Text] [Related]
11. Development of cancer chemopreventive drugs based on mechanistic approaches.
Steele VE; Kelloff GJ
Mutat Res; 2005 Dec; 591(1-2):16-23. PubMed ID: 16083917
[TBL] [Abstract][Full Text] [Related]
12. Karyometry in the early detection and chemoprevention of intraepithelial lesions.
Ranger-Moore J; Alberts DS; Montironi R; Garcia F; Davis J; Frank D; Brewer M; Mariuzzi GM; Bartels HG; Bartels PH
Eur J Cancer; 2005 Sep; 41(13):1875-88. PubMed ID: 16087328
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
Zeng L; Kyprianou N
Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876
[TBL] [Abstract][Full Text] [Related]
15. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
16. Terpenoids and breast cancer chemoprevention.
Rabi T; Bishayee A
Breast Cancer Res Treat; 2009 May; 115(2):223-39. PubMed ID: 18636327
[TBL] [Abstract][Full Text] [Related]
17. Assessing intraepithelial neoplasia and drug safety in cancer-preventive drug development.
Kelloff GJ; Sigman CC
Nat Rev Cancer; 2007 Jul; 7(7):508-18. PubMed ID: 17568791
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability is a late event in the carcinogenesis of uterine cervical cancer.
Nishimura M; Furumoto H; Kato T; Kamada M; Aono T
Gynecol Oncol; 2000 Nov; 79(2):201-6. PubMed ID: 11063644
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention with theaflavins of rat esophageal intraepithelial neoplasia quantitatively monitored by image tile analysis.
Boone CW; Stoner GD; Bacus JV; Kagan V; Morse MA; Kelloff GJ; Bacus JW
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1149-54. PubMed ID: 11097221
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of preinvasive neoplastic progression in animal models of chemical carcinogenesis.
Bacus JW; Bacus JV; Stoner GD; Moon RC; Kelloff GJ; Boone CW
J Cell Biochem Suppl; 1997; 28-29():21-38. PubMed ID: 9589347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
